Opening Breast Cancer in Young Women: Optimizing Knowledge and Care to Improve Outcomes
Breast Cancer in Young Women: Optimizing Knowledge and Care to Improve Outcomes
- Length
- 58 min
- Level
- Undergraduate
- Recorded
- Yale University2024
Chapter 1 of 9: Before the lecture
Partridge weighs POSITIVE data: pausing endocrine therapy for pregnancy did not raise short-term recurrence.
Breast cancer in women diagnosed young carries higher recurrence and mortality risk and worse quality of life than in older patients. Partridge, speaking at Yale Cancer Center Grand Rounds in November 2024, draws on SEER data and the Young Women's Breast Cancer Study, a prospective cohort. She contrasts frequent bilateral mastectomy with breast preservation and ties chemotherapy benefit in premenopausal women to ovarian function suppression. Waning endocrine therapy adherence and its survival cost lead to the POSITIVE trial of interrupting therapy for pregnancy. The Young and Strong program and audience questions on breastfeeding and hormone replacement close a talk that assumes familiarity with receptor subtypes and standard treatment.
Breast cancer in women diagnosed young carries higher recurrence and mortality risk and worse quality of life than in older patients. Partridge, speaking at Yale Cancer Center Grand Rounds in November 2024, draws on SEER data and the Young Women's Breast Cancer Study, a prospective cohort. She contrasts frequent bilateral mastectomy with breast preservation and ties chemotherapy benefit in premenopausal women to ovarian function suppression. Waning endocrine therapy adherence and its survival cost lead to the POSITIVE trial of interrupting therapy for pregnancy. The Young and Strong program and audience questions on breastfeeding and hormone replacement close a talk that assumes familiarity with receptor subtypes and standard treatment.
Breast 2022
JCO 2022
Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting
Mahmood et al, Int J Rad Oncol, 2012
Kroman et al, 2004
Kurian et al, JAMA 2014

This lecture
Talk 3 of 26 of Yale Cancer Center Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Int J Rad Oncol, 2012; Kroman et al, 2000; Kuran et al, JAMA 2014
Uuluköyü et al, Eur J Cancer 2012
Unukohya et al; Eur J Cancer 2012
Brantley et al, JAMA Onc 2024
Tracy et al; Breast Cancer Res Treat 2013
Kim HJ et al, Breast 2022
Luen SJ, et al. Ann Oncol. 2023;34(4):397-409
Brown LC, et al. J Clin Oncol. 2023;41(Suppl 16):504
Piccart et al. Ann Oncol 2021
Pagani O, et al. J Clin Oncol. 2023;41(3):479-487
Francis PA, et al. J Clin Oncol. 2023;41(3):478-1375
Partridge et al. JCO 2003, Hershman et al. JCO 2010
Dumas et al. ESMO 2024
Ruddy et al. JCO 2014; Poorvu et al. Cancer, 2020
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
Time to pregnancy study
Young Women's Breast Cancer Study (YWS)
JCO Clinical Cancer Information, 2021